Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Compounding pharmacies can make tirzepatide againIn a reversal, the Food and Drug Administration ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

From wondering what to eat for dinner to "how many calories is this bag of Takis?" But food noise becomes problematic if it’s ...

New weight-loss jabs for unemployed people to help them return to work could overwhelm “already stretched” NHS services, its ...

Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and Mounjaro, has announced a strategic ...

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...